{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T15:38:43Z","timestamp":1761838723703,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spanish Journal of Psychiatry and Mental Health"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.rpsm.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:24:48Z","timestamp":1665062688000},"page":"204-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonidine reduces the need for antipsychotics in conduct disorders associated with intellectual disability and mental illness: A case series"],"prefix":"10.1016","volume":"16","author":[{"given":"Milton","family":"Merizalde Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Castan Campanera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Pifarr\u00e9 Paredero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2022.09.004_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/dtb.2018.000009","article-title":"Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and\/or autism","volume":"57","author":"Shankar","year":"2019","journal-title":"Drug Ther Bull"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0060","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1080\/14656566.2020.1790524","article-title":"Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability","volume":"21","author":"Miller","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/070674371506000202","article-title":"The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysi","volume":"60","author":"Pringsheim","year":"2015","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2021.12.035","article-title":"Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance \u2013 results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase","volume":"146","author":"Ahmadpanah","year":"2022","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0075","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.pnpbp.2010.03.022","article-title":"Successful augmentation of clozapine-resistant treatment of schizophrenia with clonidine","volume":"34","author":"Dardennes","year":"2010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0080","first-page":"23","article-title":"Difficult to treat mania: clonidine as an option?","volume":"21","author":"Shaik","year":"2015","journal-title":"J Int Res Med an Pharm Sci"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0085","first-page":"271","article-title":"Successful treatment of auditory hallucinations in a schizophrenia patient with clonidine","volume":"32","author":"Aksu","year":"2019","journal-title":"Dusunen Adam J Psychiatry Neurol Sci"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0090","first-page":"76","article-title":"Clonidine in the management of treatment resistant adolescent-onset mania: a case report","volume":"15","author":"Mathew","year":"2019","journal-title":"J Indian Assoc Child Adolesc Ment Heal"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0095","series-title":"Diagnostic Interview for ADHD in adults with Intellectual Disability (DIVA-5-ID)","first-page":"2","author":"Kooij","year":"2017"},{"key":"10.1016\/j.rpsm.2022.09.004_bib0100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2004.05.033","article-title":"Proposal for a noradrenaline hypothesis of schizophrenia","volume":"28","author":"Yamamoto","year":"2004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"}],"container-title":["Spanish Journal of Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989122001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989122001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T15:36:03Z","timestamp":1761838563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888989122001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1888989122001070"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2022.09.004","relation":{},"ISSN":["2950-2853"],"issn-type":[{"type":"print","value":"2950-2853"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonidine reduces the need for antipsychotics in conduct disorders associated with intellectual disability and mental illness: A case series","name":"articletitle","label":"Article Title"},{"value":"Spanish Journal of Psychiatry and Mental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEP y SEPB. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}